Ledger.Open graph →
SEC Form D · filed May 10, 2019

Neuralink Corp

Offering
$51.3M
Sold
$39.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Max Hodak · San Francisco, CAExecJared Birchall · San Francisco, CAExec · DirectorMax Hodak · San Francisco, CAExecJared Birchall · Burlingame, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗